MYGN R&D Expense Growth
Myriad Genetics Inc · R&D Expense Growth
MYGN R&D Expense Growth
Latest reported-5.82%period ending
MYGN FY R&D Growth (YoY) (0.00% → -5.82%)
Latest values, visible window
High-resolution chart · PNG
MYGN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.8201% | |
| 27.8467% | |
| 3.8642% | |
| 4.2735% | |
| 1.2361% | |
| 4.7927% | |
| -10.1281% | |
| 21.3277% | |
| -4.8387% | |
| 5.3824% | |
| -6.4901% | |
| 11.8916% | |
| 25.6396% | |
| 25.9374% | |
| 53.6701% | |
| 26.8733% | |
| 22.1% | |
| -87.1782% | |
| 38.7328% | |
| 20.2383% | |
| 41.3787% | |
| 16.857% | |
| 6.5309% | |
| 31.1184% | |
| 7.3231% | |
| 20.3545% | |
| 19.5692% | |
| 2.1739% | |
| 23.6559% | |
| 43.0769% | |
| 0% |